治疗耐药晚年抑郁症的认知特征及其对治疗结果的影响
Katharina Göke1, Shawn M McClintock2, Linda Mah3
1Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
概括
晚年抑郁症 (LLD) 患者表现出认知障碍,特别是那些患有治疗耐药性抑郁症 (TRD) 患者. 三个不同的认知子组对重复性跨磁刺激 (rTMS) 治疗有着相似的反应.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 认知心理学 认知心理学
背景情况:
- 晚年抑郁症 (LLD) 与认知障碍有关,患者的变化很大.
- 在LLD中的认知缺陷,特别是耐治疗抑郁症 (TRD),需要进一步调查.
- 了解认知异质性对于有效的LLD管理至关重要.
研究的目的:
- 为了比较治疗耐药与非耐药的LLD患者的认知概况.
- 在LLD人群中识别不同的认知子组.
- 评估在认知子组中对双边重复性横磁性刺激 (rTMS) 的差异性治疗反应.
主要方法:
- 与健康对照组相比,165名LLD患者被分为耐治疗和非耐药组.
- 认知评估包括执行功能,处理速度,口头学习和记忆.
- 集群分析确定了认知子组;分析了双边rTMS的结果.
主要成果:
- 患有LLD的患者,特别是TRD,比对照患者表现较差的认知表现.
- 三个认知子组出现了:认知完整,认知减弱和记忆障碍.
- 认知下降和记忆障碍子组表现出更多的焦虑和TRD,但rTMS治疗结果在所有子组中都是相似的.
结论:
- 患有LLD的患者表现出认知障碍,在TRD中更严重.
- 三个不同的认知子组对rTMS的反应均,突出了其广泛的有效性.
- rTMS在所有认知特征中是有效的,特别是当药物不能耐受时.
相关概念视频
Cognitive Therapy
149
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
149
Cognitive Development During Adulthood
76
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
76
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Depression: Overview
230
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
230
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Depressive Disorders: Etiology
61
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
61


